Trial Information

Summary: Measuring and Predicting Response to Atomoxetine and Methylphenidate

Attention Deficit/Hyperactivity Disorder (ADHD) is one of the most frequently occurring disorders of children and adolescents, and represents a significant public health problem. There are several different medication treatment options and this study will compare two medications that are commonly prescribed. All participants will have the opportunity to try each medication. Both medications are appproved treatments by the Food and Drug Administration (FDA). All participants will be evaluated for ADHD and other conditions. Evaluations and medication provided at no cost.
Compensation Provided

Patient Inclusion/Exclusion Criteria:

Have ADHD or undiagnosed ADHD (easliy distracted, forgetful, disorganized...).
Ages 7-17.
In good health.
Able to swallow pills.
Able to attend weekly visits.

Cannot participate if have had bad reactions to Strattera or Concerta.

Contact:

Ms. Robyn C Palmero, M.A.
Mount Sinai Medical Center
One Gustave L. Levy Place

New York, NY 10029
Telephone: 877-ADHD-411
Fax: 212-849-2690
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:29:35 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA